Annandale Capital, LLC Mei Pharma, Inc. Transaction History

Annandale Capital, LLC

  • $543 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.21 - $0.35 $10,530 - $17,550
-50,144 Reduced 50.14%
49,856 $11,000
Q3 2022

Nov 14, 2022
BUY
$0.41 - $0.64 $41,000 - $64,000
100,000 New
100,000 $39,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $373M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Annandale Capital, LLC Portfolio

Follow Annandale Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annandale Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annandale Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email